Gynecological Cancer Patients Find Safety, Solidarity in Support Group

Deb Petrishen says well-meaning but frustrating interactions can occur everywhere, from the grocery store to family functions. Although friends and loved ones are often sensitive and supportive, some may not know what to say to someone with stage III ovarian cancer, especially after two recurrences. Petrishen has just as much difficulty explaining her feelings. Except … Read more

What You Should Know About Cervical Cancer [Webchat]

Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at … Read more

Drug Prolongs Remissions in Some Relapsed Ovarian Cancers

Ed. note: Niraparib (Zejula) was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2017, as a maintenance therapy for women with ovarian, fallopian tube, or primary peritoneal cancer. This post was originally published on Oct. 21, 2016. For women with relapsed ovarian cancer that responds to platinum-based chemotherapy, a drug that hampers … Read more

An Aggressive Treatment for a Strong Patient

By Theresa Sullivan Barger After triathlete Betsy Feldmann felt pressure in her abdomen while running, which seemed “as if her insides were slipping,” she saw four doctors before being diagnosed with stage II-C ovarian cancer. Feldmann chose an aggressive approach recommended by Ursula Matulonis, MD, medical director of Gynecologic Oncology at the Susan F. Smith … Read more

Treatments for Ovarian Cancer: Finding Your Path [Infographic]

Ovarian cancer is a complex disease. Cell types, stages, and genetics play an important role for patients and their doctors as they decide which direction to take. Fortunately, patients today have many treatment options and new advances on the horizon. Physician-scientists at the Susan F. Smith Center for Women’s Cancers are leading the way in … Read more

What is the Latest Research in Endometrial Cancer?

For endometrial cancer, as for virtually every form of cancer, advances in genomics are transforming the understanding and treatment of this disease, which arises in the lining of the uterus or womb. As part of the Profile research project at Dana-Farber, Brigham and Women’s Hospital, and Boston Children’s Hospital, investigators have scanned hundreds of endometrial … Read more

Improving Sexual Health for Ovarian Cancer Patients

Treatment for ovarian cancer often comes with sexual side effects. Although curing the cancer is the main goal for many patients and their doctors, Sharon Bober, PhD, director of Dana-Farber’s Sexual Health Program, is focused on preserving a patient’s quality of life – including her sexual satisfaction. Bober, with co-investigators Alexi Wright, MD, MPH, a … Read more

Clinical Trial Helps Betsy Brauser Live with Ovarian Cancer

As researchers and clinicians in the Susan F. Smith Center for Women’s Cancers at Dana-Farber continue studying the benefits of a two-drug combination in slowing progression of recurrent ovarian cancer, one patient is as a beacon of hope for her caregivers – and for others facing the disease. Betsy Brauser, treated with standard chemotherapy near … Read more

If I’ve Had a Gynecologic Cancer, Can I Have Children?

Fertility is a common concern among newly diagnosed cancer patients. For women with gynecologic cancer, the ability to have children depends on the type of cancer a woman has and the stage at which it is diagnosed, says Colleen Feltmate, MD, director of Minimally Invasive Surgery in Gynecologic Oncology at Dana-Farber/Brigham and Women’s Cancer Center. … Read more

Cancer Conversations Podcast – Episode #6: Cervical Cancer Research, Treatment and Prevention

Although cervical cancer incidence and death rates have decreased thanks to regular screenings, thousands of women in the U.S. are still affected by the disease every year. In this Cancer Conversations podcast episode, Ursula Matulonis, MD, medical director of the Gynecologic Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, joins … Read more

Cancer Conversations Podcast – Episode #3: The Latest in Ovarian Cancer Treatment and Research

Although ovarian cancer can sometimes be difficult to treat, researchers and physicians are finding new ways to approach the disease, making way for promising alternatives to the traditional chemotherapy treatments. In this Cancer Conversations podcast episode, Ursula Matulonis, MD, Panos Konstantinopoulos, MD, PhD, and Susana Campos, MD, MPH, from the Gynecologic Oncology Program at the Susan … Read more

What Are the Symptoms of Cervical Cancer?

Cervical cancer screenings, which typically include a pelvic exam and Pap smear, have significantly reduced the number of cervical cancer incidence and death rates in the United States. These screenings are especially important because symptoms of cervical cancer often go undetected until the disease is more advanced. “The vast majority of cervical cancers are early … Read more

Can Two Ovarian Cancer Drugs Succeed Where Others Have Failed?

When Donna Gregory’s ovarian cancer came back for the third time, she began looking for alternatives to chemotherapy. She’d been diagnosed with stage III ovarian cancer in 2003, at age 58. After having surgery to remove her tumors, she tried platinum-based chemotherapy, but her cancer did not respond. Several more chemotherapy drugs worked, but only … Read more

How Is Surgery Used to Treat Gynecologic Cancers?

Many associate cancer treatment with chemotherapy and radiation therapy, but for many women with gynecologic cancers, surgery is often the first line of defense. Colleen Feltmate, MD, director of minimally invasive surgery in gynecologic oncology at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), shares insight into surgical options to treat these cancers. Minimally Invasive vs. Open … Read more

Angelina Jolie Puts Spotlight on Genetic Testing and Ovarian Cancer Risk

Once again Angelina Jolie is making headlines after penning another op-ed in The New York Times. The actress shared she has undergone more cancer preventive surgery – this time prophylactic salpingo-oophorectomy, a procedure to have her ovaries and fallopian tubes removed. Two years ago, she wrote about her decision to have a prophylactic double mastectomy, … Read more